Vivani Medical (VANI) Long-Term Deferred Tax (2020 - 2024)
Vivani Medical (VANI) posted quarterly Long-Term Deferred Tax of $198.7 million for Q4 2024, up 215.33% year-over-year from $63.0 million in Q1 2024, and up 215.33% quarter-over-quarter from $63.0 million in Q4 2023.
Vivani Medical (VANI) Long-Term Deferred Tax (2020 - 2024) Analysis & Trends
Vivani Medical's Long-Term Deferred Tax history runs 5 years deep, the most recent figure standing at $198.7 million for Q4 2024.
- In Q4 2024, Long-Term Deferred Tax rose 215.33% year-over-year to $198.7 million; the TTM figure through Dec 2024 stood at $198.7 million (up 215.33% YoY), while the FY2024 annual figure was $198.7 million, up 215.33% from the prior year.
- Long-Term Deferred Tax for Q4 2024 stood at $198.7 million, up from $63.0 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $198.7 million in Q4 2024, with the low at $16.7 million in Q4 2021.
- The 5-year median for Long-Term Deferred Tax is $56.5 million (2022), against an average of $73.1 million.
- The sharpest annual moves came in 2021 and 2022: Long-Term Deferred Tax tumbled 45.24% in 2021, then jumped 238.64% in 2022.
- Vivani Medical's Long-Term Deferred Tax stood at $30.5 million in 2020, then sank by 45.24% to $16.7 million in 2021, then surged by 238.64% to $56.5 million in 2022, then climbed by 11.42% to $63.0 million in 2023, then jumped by 215.33% to $198.7 million in 2024.
- Business Quant data shows VANI's Long-Term Deferred Tax at $198.7 million in Q4 2024, $63.0 million in Q4 2023, and $56.5 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 198.67 Mn |
| Dec 31, 2023 | 63.00 Mn |
| Dec 31, 2022 | 56.55 Mn |
| Dec 31, 2021 | 16.70 Mn |
| Dec 31, 2020 | 30.49 Mn |